3PBIOVIAN
Pre-clinicalWe are an end-to-end global CDMO providing fully integrated, high-quality and tailored solutions // 3PBIOVIAN / Affinity in the making.
Founded
2015
Focus
BiologicsAntibodies
About
We are an end-to-end global CDMO providing fully integrated, high-quality and tailored solutions // 3PBIOVIAN / Affinity in the making.
Funding History
2Total raised: $17.5M
Series A$15MMaki.vcMar 15, 2023
Seed$2.5MLifeline VenturesJun 15, 2021
Company Info
TypePrivate
Founded2015
LocationTurku, Finland
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
Faron Pharmaceuticals
Phase 1/2 · Turku
Finvector Vision Therapies
Pre-clinical · Kuopio
Bone Index
Pre-clinical · Kuopio
Genomill Health
Pre-clinical · Helsinki
GlucoModicum
Pre-clinical · Helsinki
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile